Centralising ECG trial data can cut costs 40%, says ERT

By Gareth Macdonald

- Last updated on GMT

Related tags: Contract research organization

E Research Technology (ERT) launches Centralised Cardiac Safety 2.0 (CCS 2.0) service for ECG data and says approach improves efficiency, cuts costs and helps sponsors reach database lock quicker than distributed model.

Outsourcing-pharma spoke with ERT executive VP of sales and marketing John Blakeley who said allowing investigators to focus on medicine rather than on the tech used to drive trials was a key motivation for developing the new service and software.

Blakeley explained that, unlike current approaches in which ECGs are collated manually at trial sites, the CCS 2.0 model is to feed information to a centralised repository enabling real time analysis, improving data quality and reducing investigator workload.

He also suggested that centralising ECG data is 35 to 40 per cent cheaper than the decentralised approach which, given the cost pressures facing pharma firms and contract research organisations (CRO), is sure to attract industry attention.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more


View more